Advanced Health Intelligence
Riaan Conradie has a diverse and extensive work experience. Riaan is currently working as the Chief Scientist at Advanced Health Intelligence since 2022. Before that, Riaan was involved with multiple roles at LifeQ from 2015 to 2020, including Founder, Algemeen Directeur, Director, Founder & Chief Visionary Officer, and President & Co-Founder. LifeQ focused on utilizing bio-mathematical models to track physiology and improve human health. Riaan also founded and served as the Director of Vertica Health from 2020 to 2022. Prior to that, they were the CEO and Co-founder of HealthQ Technologies Pty Ltd, a high-tech startup company specializing in digital health and wellness solutions from 2007 to 2016. Riaan's academic background includes working as a Postdoc at the University of Stellenbosch, where they contributed to modeling adrenal steroidogenesis to predict and repair diseases related to steroid imbalances. Riaan also pursued undergraduate, Hons B.Sc, cum laude, and PhD studies at the University of Stellenbosch, with a focus on molecular and cellular biology, human physiology, and biochemistry.
Riaan Conradie completed their high school education at Stellenberg High School from 1996 to 2000. Riaan then pursued a PhD in Biochemistry at Stellenbosch University, which they successfully completed from 2001 to 2009. In 2005, they also attended a three-month long certificate course in Bioinformatics at NBN.
This person is not in any offices
Advanced Health Intelligence
Advanced Health Intelligence (NASDAQ:AHI, ASX:AHI) is committed to becoming a global leader in digital health. We harness proprietary technology and innovative processes to redefine health screening. Leveraging the ubiquity and convenience of smartphones, AHI aims to deliver a comprehensive suite of assessment tools globally to healthcare providers, caregivers, insurers, and governments. Our mission is to enhance healthcare delivery and support the early detection and prevention of chronic diseases. Our patented technology has evolved into a robust suite of solutions that symbolize the future of digitized healthcare. These include: • Body dimension and composition assessments, enabling the identification of obesity-related comorbidities such as diabetes. • Blood biomarker prediction, inclusive of HbA1C, HDL, LDL, and 10-year mortality risk. • Transdermal Optical Imaging, providing vital signs and cardiovascular disease risk estimates. • On-device dermatological skin identification, capable of recognizing 588 skin conditions across 133 categories, including melanoma. • Assisting partners in delivering personalized therapeutic and non-therapeutic health coaching to improve daily habits and build health literacy. Our world-class team—comprising machine learning and AI experts, computer vision specialists, and medically trained data scientists—ensures that AHI remains at the cutting edge of health-tech innovation. We aspire to create a transformative impact at scale, driving forward a new era in digital healthcare. Our biometrically derived triage solution, accessible via smartphone, enables our partners to identify and manage health risks at a population scale. Through technology, AHI contributes to a more efficient, effective, and inclusive global healthcare system. We stand ready to guide healthcare providers, caregivers, insurers, and governments in triaging individuals into the most suitable care pathways.